Live Breaking News & Updates on Pharmaceuticals Stock Down

Stay updated with breaking news from Pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells $9,203,857.52 in Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […] ....

Leonards Schleifer , Catalyst Capital Advisors , E Fund Management Co , Hedge Funds Weigh In On Regeneron Pharmaceuticals , Cantor Fitzgerald , Regeneron Pharmaceuticals Stock Down , News Ratings For Regeneron Pharmaceuticals Daily , Quarter For Regeneron Pharmaceuticals , Fund Management Co , Royal Bank , Fiera Capital Corp , Regeneron Pharmaceuticals , Capital Investment Advisors , Regeneron Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Stock Down , Capital Corp , Capital Advisors , Fund Management , Regeneron Pharmaceuticals Daily ,

Frazier Life Sciences Management L.P. Grows Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […] ....

United States , Stifel Nicolaus , Eric Bjerkholt , Saira Ramasastry , News Ratings For Mirum Pharmaceuticals Daily , Wetzel Investment Advisors Inc , Quest Partners , China Universal Asset Management Co , Stepstone Group , Insider Transactions At Mirum Pharmaceuticals , Quarter For Mirum Pharmaceuticals , Morgan Stanley , Mirum Pharmaceuticals Stock Down , Mirum Pharmaceuticals , Cantor Fitzgerald , Exchange Commission , Frazier Life Sciences Management , Mirum Pharmaceuticals Profile , Mirum Pharmaceuticals Inc , Free Report , Investment Advisors , Stone Group , Universal Asset Management , Director Saira Ramasastry , Pharmaceuticals Stock Down , Get Free Report ,

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […] ....

Diana Hausman , Stifel Nicolaus , Zentalis Pharmaceuticals Inc , News Ratings For Zentalis Pharmaceuticals Daily , Zentalis Pharmaceuticals Company Profile , Decheng Capital , Vanguard Group Inc , Pricet Rowe Associates Inc , Zentalis Pharmaceuticals Stock Down , Institutional Trading Of Zentalis Pharmaceuticals , Hermes Inc , Zentalis Pharmaceuticals , Eventide Asset Management , Get Free Report , Pharmaceuticals Stock Down , Asset Management , Federated Hermes , Zentalis Pharmaceuticals Daily ,

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […] ....

Diana Hausman , Stifel Nicolaus , Zentalis Pharmaceuticals Stock Down , Zentalis Pharmaceuticals Inc , Vanguard Group Inc , Pricet Rowe Associates Inc , Decheng Capital , Zentalis Pharmaceuticals , Eventide Asset Management , Zentalis Pharmaceuticals Company Profile , Hermes Inc , News Ratings For Zentalis Pharmaceuticals Daily , Institutional Trading Of Zentalis Pharmaceuticals , Get Free Report , Pharmaceuticals Stock Down , Asset Management , Federated Hermes , Zentalis Pharmaceuticals Daily ,

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Barometer Capital Management Inc.

Barometer Capital Management Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,487 shares of the pharmaceutical company’s stock after selling 3,342 shares during the period. Vertex Pharmaceuticals makes up approximately 1.2% […] ....

Carmen Bozic , Ourania Tatsis , A Davidson , Barometer Capital Management Inc , Quarter For Vertex Pharmaceuticals , Securities Exchange Commission , Da Davidson , Ellevest Inc , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals , Canaccord Genuity Group , News Ratings For Vertex Pharmaceuticals Daily , Blair William Co , Wolfe Research , Vertex Pharmaceuticals Stock Down , Barometer Capital Management , Free Report , Capital Management , Pharmaceuticals Stock Down , Pharmaceuticals Incorporated , Get Free Report , Exchange Commission , Genuity Group , Vertex Pharmaceuticals Daily ,